Kario, Kazuomi and Park, Sungha and Chia, Yook-Chin and Sukonthasarn, Apichard and Turana, Yuda and Shin, Jinho and Chen, Chen-Huan and Buranakitjaroen, Peera and Divinagracia, Romeo and Nailes, Jennifer and Hoshide, Satoshi and Siddique, Saulat and Sison, Jorge and Soenarta, Arieska Ann and Sogunuru, Guru Prasad and Tay, Jam Chin and Teo, Boon Wee and Zhang, Yu-Qing and Minh, Huynh Van and Tomitani, Naoko and Kabutoya, Tomoyuki and Verma, Narsingh and Wang, Tzung-Dau and Wang, Ji-Guang (2020) 2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network. Journal of Clinical Hypertension, 22 (3). pp. 351-362. ISSN 1524-6175, DOI https://doi.org/10.1111/jch.13751.
Full text not available from this repository.Abstract
Hypertension professionals from Asia have been meeting together for the last decade to discuss how to improve the management of hypertension. Based on these education and research activities, the Hypertension, brain, cardiovascular and renal Outcome Prevention and Evidence in Asia (HOPE Asia) Network was officially established in June 2018 and includes experts from 12 countries/regions across Asia. Among the numerous research and review papers published by members of the HOPE Asia Network since 2017, publications in three key areas provide important guidance on the management of hypertension in Asia. This article highlights key consensus documents, which relate to the Asian characteristics of hypertension, home blood pressure monitoring (HBPM), and ambulatory blood pressure monitoring (ABPM). Hypertension and hypertension-related diseases are common in Asia, and their characteristics differ from those in other populations. It is essential that these are taken into consideration to provide the best opportunity for achieving ``perfect 24-hour blood pressure control'', guided by out-of-office (home and ambulatory) blood pressure monitoring. These region-specific consensus documents should contribute to optimizing individual and population-based hypertension management strategies in Asian country. In addition, the HOPE Asia Network model provides a good example of the local interpretation, modification, and dissemination of international best practice to benefit specific populations.
| Item Type: | Article |
|---|---|
| Funders: | Pfizer, Daichi Sankyo, Omron Healthcare, AD, Fukuda Denshi Co. Ltd. |
| Uncontrolled Keywords: | Ambulatory blood pressure monitoring; Asia; Cardiovascular disease; Guidelines; Home blood pressure monitoring; Hypertension |
| Subjects: | R Medicine > R Medicine (General) |
| Divisions: | Faculty of Medicine |
| Depositing User: | Ms Zaharah Ramly |
| Date Deposited: | 02 Dec 2022 07:36 |
| Last Modified: | 02 Dec 2022 07:36 |
| URI: | http://eprints.um.edu.my/id/eprint/38137 |
Actions (login required)
 |
View Item |
